Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

1. Plumbagin Disrupts Biofilm Integrity and Resistance Gene Expression in Carbapenem-ResistantJournal of microbiology and biotechnology · 2026
   Article
2. The Antifungal Effects of Equol AgainstJournal of fungi (Basel, Switzerland) · 2025
   Article
3. Infection and drug resistance · 2025
   Article
4. Fingolimod potentiates the antifungal activity of fluconazole against fluconazole-resistantFrontiers in cellular and infection microbiology · 2025
   Article
5. Antifungal activities of Equol againstVirulence · 2024
   Article
6. Antibacterial and Anti-biofilm Effects of Thymoquinone Against Carbapenem-Resistant UropathogenicIndian journal of microbiology · 2024
   Article
7. Clinical risk factors and outcomes of carbapenem-resistantMicrobiology spectrum · 2024
   Article
8. Fingolimod synergizes and reversesFrontiers in microbiology · 2024
   Article
9. Impact of short chain fatty acids (SCFAs) on antimicrobial activity of new β-lactam/β-lactamase inhibitor combinations and on virulence of Escherichia coli isolates.The Journal of antibiotics · 2023
   Article
10. Out of control: The need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO).Biofilm · 2022
    Article
11. Anti-bacterial and Anti-biofilm Effects of Equol onIndian journal of microbiology · 2022
    Article
12. Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
13. Present and Future Perspectives on Therapeutic Options for Carbapenemase-ProducingMicroorganisms · 2021
    Review
14. Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.Gut microbes
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as